Twist Bioscience: Expansion Efforts Continue To Face Challenges

Twist Bioscience (NASDAQ: TWST ) reported solid results in the second quarter of FY2025, but the management team appeared downbeat on the earnings call. Twist has also chosen to spin out its data storage segment, with a fairly modest value attached to the business. TheRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess risk adjusted returns can be achie ...